These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4316 related articles for article (PubMed ID: 3105864)

  • 1. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
    Hart DA; Smith R
    Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
    Rehemtulla A; Gates J; Hart DA
    Comp Biochem Physiol B; 1987; 88(1):277-83. PubMed ID: 3119281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: lack of association with in vitro invasion.
    Huijzer JC; Uhlenkott CE; Meadows GG
    Int J Cancer; 1995 Sep; 63(1):92-9. PubMed ID: 7558459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C; Kruithof EK; Schleuning WD
    J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
    Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
    Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
    Rondeau E; Guidet B; Lacave R; Bens M; Sraer J; Nagamine Y; Ardaillou R; Sraer JD
    Biochim Biophys Acta; 1990 Nov; 1055(2):165-72. PubMed ID: 2122915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis.
    Gopalakrishna R; Barsky SH
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):612-6. PubMed ID: 3422445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562).
    Oliver LJ; Keeton M; Wilson EL
    Blood; 1989 Sep; 74(4):1321-7. PubMed ID: 2504306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
    Wagner OF; Vetterlein M; Binder BR
    J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate chain analysis by lectin binding to electrophoretically separated glycoproteins from murine B16 melanoma sublines of various metastatic properties.
    Irimura T; Nicolson GL
    Cancer Res; 1984 Feb; 44(2):791-8. PubMed ID: 6692378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
    Eaton DL; Baker JB
    J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
    Niiya K; Nsimba M; Hayashi T; Sakuragawa N
    Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of plasminogen activator in 3T3 cells: effect of phorbol myristate acetate on subcellular distribution and molecular weight.
    Jaken S; Black PH
    J Cell Biol; 1981 Sep; 90(3):727-31. PubMed ID: 7197280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
    Kole KL; Gyetko MR; Simpson RU; Sitrin RG
    Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 216.